Editas Medicine Inc (EDIT)
5.315
+0.10
(+1.82%)
USD |
NASDAQ |
Apr 26, 16:00
5.33
+0.02
(+0.28%)
After-Hours: 18:48
Editas Medicine Revenue (TTM): 78.12M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 78.12M |
| September 30, 2023 | 24.61M |
| June 30, 2023 | 19.32M |
| March 31, 2023 | 22.79M |
| December 31, 2022 | 19.71M |
| September 30, 2022 | 25.64M |
| June 30, 2022 | 31.80M |
| March 31, 2022 | 25.82M |
| December 31, 2021 | 25.54M |
| September 30, 2021 | 24.49M |
| June 30, 2021 | 81.14M |
| March 31, 2021 | 91.51M |
| December 31, 2020 | 90.73M |
| September 30, 2020 | 91.60M |
| June 30, 2020 | 32.60M |
| March 31, 2020 | 24.18M |
| Date | Value |
|---|---|
| December 31, 2019 | 20.53M |
| September 30, 2019 | 14.37M |
| June 30, 2019 | 25.04M |
| March 31, 2019 | 30.08M |
| December 31, 2018 | 31.94M |
| September 30, 2018 | 29.48M |
| June 30, 2018 | 21.25M |
| March 31, 2018 | 16.97M |
| December 31, 2017 | 13.73M |
| September 30, 2017 | 10.96M |
| June 30, 2017 | 5.639M |
| March 31, 2017 | 5.93M |
| December 31, 2016 | 6.053M |
| September 30, 2016 | 5.947M |
| June 30, 2016 | 5.655M |
| March 31, 2016 | 2.434M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.37M
Minimum
Sep 2019
91.60M
Maximum
Sep 2020
40.50M
Average
25.54M
Median
Dec 2021
Revenue (TTM) Benchmarks
| Vertex Pharmaceuticals Inc | 9.869B |
| Moderna Inc | 6.754B |
| Amicus Therapeutics Inc | 399.36M |
| Geron Corp | 0.237M |
| Regeneron Pharmaceuticals Inc | 13.12B |